Clinical Trials Directory

Trials / Unknown

UnknownNCT04256096

Randomization of Endovascular Treatment in Acute Ischemic Stroke in the Extended Time Window

Randomization of Endovascular Treatment With Stent-retriever and/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke Due to Large VEssel OcclusioN Trial in the Extended Time Window

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
376 (estimated)
Sponsor
Hospital de Clinicas de Porto Alegre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A phase III, randomized, multi-center, open label clinical trial that will examine whether endovascular treatment is superior to standard medical therapy alone in patients who suffer a large vessel anterior circulation ischemic stroke within 8-24 hours from time last seen well

Detailed description

Prospective, multi-center, randomized, controlled, open-label, blinded-endpoint trial with a sequential design. The randomization employs a 1:1 ratio of mechanical thrombectomy with stent-retriever and/or thromboaspiration versus medical management alone in patients who suffer a large vessel anterior circulation ischemic stroke between 8 and 24 hours from time last seen well. Randomization will be done under a minimization process using age (≤68 vs. \>68 years), baseline NIHSS (\<17 v. ≥17), ASPECTS (5-7 vs. 8-10), therapeutic window (6-12 or 12-24 hours after TLKW), occlusion site (Intracranial ICA or M1), and clinical site. For the primary endpoint, subjects will be followed for 90 days post-randomization. Sham endovascular procedure has been rejected due to the medical risk of the angiography and practical issues that difficult to maintain blindness of investigators.

Conditions

Interventions

TypeNameDescription
DEVICEThrombectomyEndovascular treatment of large vessel occlusion (mechanical thrombectomy) with stent-retriever and/or thromboaspiration (neurointerventionalist choice)

Timeline

Start date
2020-03-09
Primary completion
2022-02-01
Completion
2022-05-01
First posted
2020-02-05
Last updated
2021-02-10

Locations

14 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04256096. Inclusion in this directory is not an endorsement.